Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 29 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

34%

10 trials in Phase 3/4

Results Transparency

26%

5 of 19 completed with results

Key Signals

5 with results100% success

Data Visualizations

Phase Distribution

25Total
Not Applicable (11)
P 1 (1)
P 2 (3)
P 3 (4)
P 4 (6)

Trial Status

Completed19
Unknown6
Not Yet Recruiting2
Recruiting1
Withdrawn1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 19 completed trials

Clinical Trials (29)

Showing 20 of 20 trials
NCT07541651Not Yet Recruiting

Study on Eye-Brain Cross-Organ Mapping and Systemic Disease Association Based on Multimodal Big Data

NCT07228091Recruiting

Surgical Procedure Efficiency Evaluation stuDy

NCT07054281Not ApplicableWithdrawn

UNITY VCS Vitreoretinal Surgery

NCT06559488Not ApplicableCompleted

IVB for Post-vitrectomy Hemorrhage in Diabetic Eyes

NCT06383754Not ApplicableCompleted

Clareon Intraocular Lens Stability in Vitrectomy Patients: CLOVE Study

NCT06343961Not ApplicableNot Yet Recruiting

Intraoperative Application of Fluorescein Sodium Angiography in Vascular Retinopathy

NCT01805297Phase 2CompletedPrimary

Aflibercept Injection for Proliferative Diabetic Retinopathy

NCT05529589Unknown

Comparison of Restoration in Vitreous Hemorrhage Patients With DME After or Not Removing Inner Limiting Membrane

NCT05710458Not ApplicableCompleted

Performance Comparison of the 25 Gauge 20,000cpm HYPERVIT Dual Blade vs. 10,000cpm ULTRAVIT Vitrectomy Cutter

NCT05588037Not ApplicableUnknown

Combined Vitrectomy and Femtosecond Laser-assisted Cataract Surgery

NCT05514925Phase 4Unknown

Cryoapplication Versus Anti-VEGF Before Diabetic Vitrectomy

NCT04404296Not ApplicableUnknown

Pars Plana Vitrectomy With 25-gauge 20000 Cpm, Bevel-tip Cutter

NCT04859556Not ApplicableCompletedPrimary

Performance, Safety and Efficiency Comparison Between 10,000 and 5,000 Cuts Per Minute Vitrectomy Using a 25G Cutter - A Prospective Randomized Controlled Study

NCT02858076Phase 2Completed

Anti-VEGF vs. Prompt Vitrectomy for VH From PDR

NCT04712786Completed

Refractive Changes Following Vitrectomy

NCT04346095Phase 4Unknown

Oral Sedation in Vitreoretinal Surgery

NCT00996437Phase 2CompletedPrimary

Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy (N)

NCT00745498Not ApplicableCompleted

Pre- and Intra-operative Intravitreal Bevacizumab Injection in Diabetic Vitrectomy

NCT01854593Phase 4Completed

Prospective Randomized Controlled Study of Intravitreal Injection of Bevacizumab for Proliferative Diabetic Retinopathy

NCT02151305Not ApplicableCompleted

Different Hemostasis According to the Anesthetic Agents

Scroll to load more

Research Network

Activity Timeline